logo
Plus   Neg
Share
Email

XFOR Prices Offering At $12/Shr

X4 Pharmaceuticals, Inc. (XFOR) plans to sell 3.66 million shares of its common stock at $12 per share. The gross proceeds from the offering are expected to be approximately $65.0 million. The offering is slated to close on or about November 29, 2019.

Cowen and Stifel are acting as joint book-running managers for this offering.

Canaccord Genuity and Oppenheimer & Co. are acting as lead managers, and H.C. Wainwright & Co. and Roth Capital Partners are acting as managers for the offering.

X4 Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases.

The lead drug candidate is Mavorixafor.

A pivotal Phase 3 clinical trial of Mavorixafor for the treatment of WHIM syndrome is underway. The 52-week trial is designed to enroll 18 to 28 subjects in
approximately 20 countries, followed by an open-label extension trial.

Mavorixafor is also being explored in other indications like Severe Congenital Neutropenia and advanced clear cell renal cell carcinoma. The Company is also in preparations to begin Phase 1b clinical trial of Mavorixafor in Waldenström's macroglobulinemia later this quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. U.S. President Donald Trump has issued executive orders to ban Chinese mobile application TikTok as well as WeChat, citing a threat to national security and its economy. China's ByteDance Ltd. owns TikTok, a video-sharing mobile app, while Tencent Holdings Ltd. owns WeChat, a messaging, social media, and electronic payment app.
Follow RTT